Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999
Journal of the American College of CardiologyPublished 1 December 2000
William J. Rogers, John G. Canto, Costas T. Lambrew, Alan J. Tiefenbrunn, Becky Kinkaid, David Shoultz
Citations658
SJR quartileQ1
SJR score9.02
SNIP6.30
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The NRMI data demonstrate that the recommendations of recent clinical trials and published guidelines are being implemented, resulting in more rapid administration of intravenous thrombolytic therapy, increasing use of primary angioplasty and more frequent use of adjunctive therapies known to reduce mortality, and may be contributing to the higher prevalence of non-Q wave infarctions, shorter hospital stays and lower hospital mortality.
Abstract
The NRMI data from 1990 through 1999 demonstrate that the recommendations of recent clinical trials and published guidelines are being implemented, resulting in more rapid administration of intravenous thrombolytic therapy, increasing use of primary angioplasty and more frequent use of adjunctive therapies known to reduce mortality, and may be contributing to the higher prevalence of non-Q wave infarctions, shorter hospital stays and lower hospital mortality.
Keywords
Medicine
Progress in Cardiovascular DiseasesBeta blockade during and after myocardial infarction: An overview of the randomized trials
3,239 Citations1985Salim Yusuf, Richard Peto +3 more
The aim has been not only to review the 65-odd randomized beta blocker trials but also to demonstrate that when many randomized trials have all applied one general approach to treatment, it is often not appropriate to base inference on individual trial results.
PubMedRandomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
2,873 Citations1988R B Sleight, Peter Sleight +4 more
The LancetEFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
2,451 Citations1986GRUPPOITALIANOPERLOSTUDIODELL
Journal of the American College of CardiologyACC/AHA guidelines for the management of patients with acute myocardial infarction
1,853 Citations1996Thomas J. Ryan, Jeffrey L. Anderson +20 more
These practice guidelines are intended to assist physicians and other healthcare providers in clinical decision making by describing a range of generally acceptable approaches for the diagnosis, management, or prevention of specific diseases or conditions.
The LancetInvasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
1,305 Citations1999
The early invasive approach should be the preferred strategy in most patients with unstable coronary-artery disease who have signs of ischaemia on electrocardiography or raised biochemical markers of myocardial damage.
CirculationNifedipine
1,181 Citations1995Curt D. Furberg, Bruce M. Psaty +1 more
In patients with coronary disease, the use of short-acting nifedipine in moderate to high doses causes an increase in total mortality, and other calcium antagonists may have similar adverse effects, in particular those of the dihydropyridine type.
New England Journal of MedicineComparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
1,019 Citations1989The TIMI Study Group*
The ejection fraction and the incidence of death in the two groups were similar during the hospital period and total mortality within the first 6 days and at 42 days was also similar; the latter comparison was considered statistically significant according to the study criteria.
The LancetSingle-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial
873 Citations1999Frans Van de Werf
Tenecteplase and alteplase were equivalent for 30-day mortality and the ease of administration of tenecteplase may facilitate more rapid treatment in and out of hospital.
New England Journal of MedicineOutcomes in Patients with Acute Non–Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy
804 Citations1998William E. Boden, Robert A. O’Rourke +10 more
Patients assigned to the invasive strategy had worse clinical outcomes during the first year of follow-up, and patients assigned to a conservative strategy had better clinical outcomes During an average follow- up of 23 months.
CirculationIndications for ACE Inhibitors in the Early Treatment of Acute Myocardial Infarction
554 Citations1998
These results support the use of ACE inhibitors early in the treatment of acute MI, either to a wide range of patients or selectively in patients with anterior MI and in those at increased risk of death.
Annals of Internal MedicineCritical Pathways as a Strategy for Improving Care: Problems and Potential
498 Citations1995Steven D. Pearson, Dorothy Goulart-Fisher +1 more
In recent years, intense pressures to reduce the costs of health care have led many health care organizations to seek strategies that reduce resource utilization while maintaining the quality of care, among the most popular of the methods intended to meet this challenge are critical pathways.
CirculationTreatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.
477 Citations1994William J. Rogers, Laura J. Bowlby +7 more
This large registry experience suggests that management of myocardial infarction in the United States does not yet conform to many of the recent clinical trial recommendations, and thrombolytic therapy is underused, particularly in the elderly and late presenters.
Survey of AnesthesiologyOutcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy
326 Citations1999William E. Boden, Robert A. O’Rourke +9 more
Most patients with non-Q-wave myocardial infarction do not benefit from routine, early invasive management consisting of coronary angiography and revascularization, and a conservative, ischemia-guided initial approach is both safe and effective.
JAMAEffects of Prophylactic Lidocaine in Suspected Acute Myocardial Infarction
320 Citations1988Stephen MacMahon
An overview of all the trial results does not provide good evidence as to whether prophylactic lidocaine is likely to be helpful or harmful; to answer this question reliably, future trials will need to involve large numbers of patients and prolonged follow-up.
CirculationUse of Reperfusion Therapy for Acute Myocardial Infarction in the United States
318 Citations1998Hal V. Barron, Laura J. Bowlby +6 more
Increased use of reperfusion therapy could potentially reduce the unnecessarily high mortality rates observed in women, the elderly, and other patient groups with the highest risk of death from an acute myocardial infarction.
Annals of Internal MedicineOutcome of Patients with Acute Myocardial Infarction Who Are Ineligible for Thrombolytic Therapy
192 Citations1991David R. Cragg, Harold Friedman +6 more
Thrombolytic therapy is currently used in the United States for only a minority of patients with acute myocardial infarction: those who have low-risk prognostic characteristics.
PubMedRoutine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
132 Citations1990Salim Yusuf, Peter Sleight +2 more
The aggregate of all trials of the routine use of calcium antagonists or antiarrhythmic agents indicates that these agents do not improve survival.
Journal of the American College of CardiologyA comparison of the National Registry of Myocardial Infarction 2 with the Cooperative Cardiovascular Project
120 Citations1999Nathan R. Every, Paul D Frederick +4 more
It is concluded that the simpler case ascertainment and data collection strategies employed by NRMI 2 result in process and outcome measures that are comparable to the more rigorous methods utilized by the CCP.
Journal of the American College of CardiologyImplications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: A comparison of thrombolytic therapy and primary angioplasty
91 Citations1995Gregg W. Stone, Cindy L. Grines +12 more
The development of recurrent ischemia adversely affects patient outcome, increasing morbidity, mortality and resource utilization, and safe early discharge on day 3 after primary coronary angioplasty should be feasible in selected patients with acute myocardial infarction.
International Journal of CardiologyProphylactic lidocaine in suspected acute myocardial infarction
47 Citations1984Heather Dunn, C.D. Kinney +3 more
Although therapeutic plasma levels were reached, 2 of 24 patients with acute myocardial infarction had ventricular tachycardia or ventricular fibrillation and 3 of 50 became hypotensive during the first hour of lidocaine.
The American Journal of CardiologyConsultation before thrombolytic therapy in acute myocardial infarction
17 Citations1999Nadim Al‐Mubarak, William J. Rogers +3 more
Among 57,398 thrombolytic recipients in the National Registry of Myocardial Infarction 2, consultation with another physician was sought in 64% before initiating lytic therapy, although presenting features were typical, rather than atypical, in most patients.